In studies, the drug was found to statistically improve sleep onset and maintain when compared to the placebo. Dayvigo was also not found to cause rebound insomnia, a common problem with some sleep medications.
FDA Approves New Sleep Drug With Claims Of Less Risk Of Unpleasant Side Effects
